Follow us on:
Breaking News
May 1, 2026
CP Direct: Friday Edition
Breaking News
FederalEquipment _ENL_050126_650x90

The Friday Brief for May 1, 2026: Launching ‘Contract Pharma Stream’

 
The Friday Brief for May 1, 2026: Launching ‘Contract Pharma Stream’

This week, Contract Pharma visited an expanding New Jersey facility, and launched a new audience service.
Watch Now >>

Top Headlines

Breaking News

Siegfried Acquires Noramco, Purisys and Extractas From SK Capital

Sigfried adds API and specialty-chemistry assets; SK Capital retains finished-dose platform Halo.

SPONSOR

Boost Biosimilar Yields with Efficient-Pro Medium

See how Fresenius Kabi boosted titers, improved glycans, and reduced variants with Gibco Efficient-Pro Medium—ready for scale.

Breaking News

Cardioline Acquires Cardios

The companies’ complementary strengths span the full cardiac diagnostic journey.

Breaking News

Evotec Receives Grants from Gates Foundation to Advance Tuberculosis Treatment

The grant programs will expand Evotec’s pipeline of novel TB drug candidates and advance the most promising combinations toward clinical evaluation.

SPONSOR

[WEBINAR] Operational Excellence for CDMOs: A Digital Workflow Strategy for Growth

Join ECOLAB and Contract Pharma for a webinar on May 6 to learn how leading CDMOs can drive growth using smarter workflows and digital tools to reduce bottlenecks and improve efficiency.  

CP-Stream_ContentHub_650x250

Breaking News
Promotions & Moves

Halozyme Appoints Darren Snellgrove as Chief Financial Officer

Snellgrove brings 30+ years of financial leadership, strategic insight, and operational excellence across the biopharmaceutical and medtech sectors.

Expert’s Opinion

The Evolving Role of CDMOs in Shaping Clinical Trial Success 

As sponsor needs change strategic collaboration with CDMOs/CROs is becoming more important for execution and early input.

SPONSOR

[eBook] Patient-Centric-Trials: Driving Sponsor Value & Operational Excellence

Clinical research is undergoing a major transformation as patient-centricity becomes the foundation of trial design and execution.

Featured Resources

Solution Center SPOTLIGHT

FAMAR

FAMAR is a leading European CDMO with over 75 years of experience, providing end-to-end solutions for the pharmaceutical and healthcare industries. With 7 manufacturing sites and 2 R&D centers across Germany, Greece, Italy, and Spain, it delivers quality, compliance and value across a broad portfolio of finished dosage forms.

 

Solution Center SPOTLIGHT

Sino Biological

Sino Biological is a leading global CRO with 18+ years’ expertise in protein production and antibody development. Our proprietary recombinant production platforms enable efficient HTP expression to kg-scale manufacturing. We offer integrated services from antibody discovery to engineering and production, accelerating your path from bench to clinic.